BetterLife Pharma (BETRF) Change in Account Payables (2012 - 2026)

BetterLife Pharma's Change in Account Payables history runs 12 years deep, the most recent figure standing at $125037.3 for Q2 2026.

• In Q2 2026, Change in Account Payables fell 52.15% year-over-year to $125037.3; the TTM figure through Apr 2026 stood at $584246.9 (up 77.63% YoY), while the FY2026 annual figure was $174310.9, up 127.37% from the prior year.
• Change in Account Payables for Q2 2026 stood at $125037.3, down from $273395.5 in the prior quarter.
• The five-year high for Change in Account Payables was $1.2 million in Q1 2023, with the low at -$1.1 million in Q1 2024.
• The 5-year median for Change in Account Payables is $134175.5 (2026), against an average of $86546.5.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 578.77% in 2022, then jumped 1611.68% in 2025.
• BetterLife Pharma's Change in Account Payables stood at $208852.4 in 2022, then slipped by 25.0% to $156629.0 in 2023, then gained by 10.26% to $172697.1 in 2024, then soared by 58.31% to $273395.5 in 2025, then plunged by 54.27% to $125037.3 in 2026.
• Business Quant data shows BETRF's Change in Account Payables at $125037.3 in Q2 2026, $273395.5 in Q3 2025, and $261316.7 in Q2 2025.